Safety and efficacy of intranasal insulin in patients with Alzheimer's disease: a systematic review and meta-analysis.

J Clin Transl Res · 2023 · PMC10411979 · PMID 37564252

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

might be significantno p-value reported

The findings of our meta-analysis revealed that intranasal insulin might be significant in improving cognition in Alzheimer’s disease patients measured by ADAS-cog with lower doses being more effective.

also in 2,435 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.